Does anyone else have the impression that PBS decision-making is suffering from a dangerous lack of political and policy interest?
-
Latest News
'Everybody says it about their strategy but this is why ours is different'
Stuart Arbuckle is the executive vice president and chief operating officer of Vertex. He spoke with BioPharmaDispatch during a trip to Australia last week.
-
Latest News One didn't ask and it appears that the other didn't want to do the work March 20, 2023
-
Latest News Industry teams raise close to $400,000 as MSD takes 'Pharma Cup' March 20, 2023Contributions can still be made to the 2023 'Kosi Challenge' but MSD has taken this year's 'Pharma Cup' while an industry executive has also raised the single largest amount by an individual.
-
Latest News Organon partners with foundation to relaunch 'No Limits 4 Girls' program March 20, 2023Sister2sister vice chair Alecia Wood and welfare manager Linda Beuzeville visited Organon on International Women's Day and spoke about the importance of supporting girls as they develop their sense of place in society.
-
Latest News Moderna officially launches Australian mRNA fellowship program March 20, 2023With this program, we can help Australia’s world-class medical research and biotech community to be at the forefront of contributions to unlocking the potential of mRNA science," said Moderna general manager Michael Azrak.
-
Latest News BeiGene president on why the company chooses 'disruption' March 17, 2023Dr Xiaobin Wu is BeiGene’s president, its chief operating officer and the general manager of the company in China. Dr Wu spoke with BioPharmaDispatch during his current visit to Australia.
-
Podcast The 'Week in Review' - 17 March March 17, 2023A change in the membership of the federal government's HTA review reference committee. What does it say about the review and what does it mean? Still waiting for final outcomes ahead of the 1 April price changes and a question from the audience about what patients can do to ensure their voices are heard.
-
Latest News A finely made point that raises more questions than it answers March 17, 2023Taken at face value, it means that the minister's own officials did not communicate the company's intention to remove these medicines from the PBS as a result of the catch-up reduction.
-
Latest News Frustration for Australian company looking to secure funding for home-grown innovation March 17, 2023The Perth-based company said the response of Australian payers to the home-grown innovation stands in stark contrast to the "traction" gained in the US and UK.
-
Latest News Company team fundraising hits surge with just one day to go March 17, 2023The pharmaceutical company teams supporting Rare Cancers Australia and this week's 'Kosi Challenge' added almost $50,000 to the fundraising total yesterday with the annual event just one day away.
-
Latest News Patient group wants a rethink on pain management decision March 16, 2023A leading patient organisation says the decision to reduce access to paracetamol will significantly hit people on low incomes and those living in rural and regional areas
-
Latest News First of its kind study now recruiting Australians on insulin therapy March 16, 2023A ground-breaking Australian and world-first study examining a new non-surgical treatment for Type 2 diabetes is now being expanded to include people in advanced stages of the disease.
-
Latest News What does this decision say about the review process and the likely outcome? March 15, 2023What has John Young observed that led him to choose his new corporate responsibilities over the review? What does this say about the review in which so much hope is invested?
-
Latest News The uncomfortable truth for the industry of a new Budget reality March 15, 2023The post-pandemic Budget reality does not make a renewed policy assault on the PBS inevitable but it certainly increases the likelihood.
-
Latest News The great curiosity of the savings and where they're being spent March 15, 2023Just two weeks to go until the single largest day of medicine price reductions in the history of the PBS and there is still no real insight into what the industry is 'on the hook' to deliver.
-
Latest News Supply chain facing significant pressures ahead of catch-up reduction day March 14, 2023The medicines supply chain is experiencing the practical challenges of 1 April's catch-up statutory price reduction and is yet to even receive confirmation of the final outcomes.
-
Latest News Sanofi launches recruitment drive for its Translational Science Hub in Queensland March 14, 2023Sanofi has opened the first tranche of senior medical research career opportunities available at its Translational Science Hub in Queensland.
-
Latest News Pfizer announces US$43bn acquisition of cancer medicines company March 14, 2023“Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,” said Dr Albert Bourla, Pfizer chairman and CEO.
-
Latest News The long wait is finally over for New Zealand's lung cancer patients March 13, 2023New Zealand's controversial medicines purchasing agency Pharmac has announced that it will fund MSD's KEYTRUDA (pembrolizumab) and Roche's TECENTRIQ (atezolizumab) for people with locally advanced and metastatic non-small cell lung cancer.
-
Latest News Australian company surges on FDA approval of innovative therapy March 13, 2023The market capitalisation of Australian company Neuren Pharmaceuticals has surged 20 per cent to almost $1 billion after it announced that the US FDA has approved its treatment for Rett syndrome.
Australian Biotech
-
Monash University in new partnership with leading Israeli research hospital
March 20, 2023 -
Australian company Clinuvel initiates second trial of new anti-stroke candidate
March 20, 2023 -
Moderna officially launches Australian mRNA fellowship program
March 20, 2023 -
Interim analysis shows accuracy of Optiscan Imaging platform
March 15, 2023 -
Patrys' says preclinical data supports synthetic lethality mechanism
March 15, 2023
Other Health
-
Ombudsman's 'State of the Health Funds Report' confirms a decline in complaints
March 20, 2023 -
Aurora Healthcare and Medibank partner to boost access to mental health care
March 20, 2023 -
Bupa says raising awareness a first step to addressing the risk of glaucoma
March 14, 2023 -
Medibank's Amplar Health extends partnership aimed at addressing GP access challenge
March 13, 2023 -
Medibank partners with RACGP to fund research into digital health in primary care
March 8, 2023
Latest Video
New Stories
-
Ombudsman's 'State of the Health Funds Report' confirms a decline in complaints
March 20, 2023 - - Other Health -
Aurora Healthcare and Medibank partner to boost access to mental health care
March 20, 2023 - - Other Health -
Bupa puts First Nations Health at the centre of Reconciliation Action Plan
March 20, 2023 - - Latest News -
Monash University in new partnership with leading Israeli research hospital
March 20, 2023 - - Australian Biotech -
Australian company Clinuvel initiates second trial of new anti-stroke candidate
March 20, 2023 - - Australian Biotech -
Organon partners with foundation to relaunch 'No Limits 4 Girls' program
March 20, 2023 - - Latest News -
Moderna officially launches Australian mRNA fellowship program
March 20, 2023 - - Latest News